Bone and cancer: Pathophysiology and treatment of metastases
- 1 August 1995
- journal article
- Published by Elsevier BV in Bone
- Vol. 17 (2), S101-S105
- https://doi.org/10.1016/8756-3282(95)00194-i
Abstract
No abstract availableThis publication has 18 references indexed in Scilit:
- Lack of variation of plasma beta-endorphin after clodronate infusion in patients with increased bone resorptionCurrent Therapeutic Research, 1993
- Effective treatment of malignant hypercalcaemia with a single intravenous infusion of clodronateBritish Journal of Cancer, 1993
- Double-blind controlled trial of oral clodronate in patients with bone metastases from breast cancer.Journal of Clinical Oncology, 1993
- A double-blind, crossover trial of intravenous clodronate in metastatic bone painJournal of Pain and Symptom Management, 1992
- An evaluation of the potential cost reductions resulting from the use of clodronate in the treatment of metastatic carcinoma of the breast to boneBone, 1991
- BisphosphonatesDrugs, 1991
- Osteoclast inhibition by pamidronate in metastatic prostate cancer: a preliminary studyBritish Journal of Cancer, 1991
- COMPARISON OF THREE INTRAVENOUS BISPHOSPHONATES IN CANCER-ASSOCIATED HYPERCALCAEMIAThe Lancet, 1989
- LONG-TERM CONTROLLED TRIAL WITH DIPHOSPHONATE IN PATIENTS WITH OSTEOLYTIC BONE METASTASESThe Lancet, 1983
- The pathophysiology of hypercaemiaMetabolic Bone Disease and Related Research, 1980